Skip to main content
. 2013 Oct 10;13:471. doi: 10.1186/1471-2407-13-471

Figure 5.

Figure 5

Targeting AKT/mTOR had a therapeutic significance on ALK + tumor cells. (A) Synergistic growth inhibition between the dual PI3K/mTOR inhibitor, NVP-BEZ235, and Dex in all cells, especially in BaF3/NPM-ALK. (B) A higher apoptosis rate in cells treated with NVP-BEZ235 and Dex together compared with single use of the drugs.